Join us at FLORetina 2025 to discover how AI is transforming daily clinical workflows, personalizing patient management, optimizing treatment strategies, and enabling faster and smarter clinical trials.

From AI-powered analytics and precision medicine to enhanced decision-making and streamlined trial operations, experience firsthand how RetinAI is shaping the future of eye care.

Book a meeting with our team and see the technology in action!

‍

See LuxIA® in action!

Come by our stand and learn about our latest AI-powered screening in adult diabetics for more-than-mild diabetic retinopathy (mtmDR) from Color fundus images.

Co-developed by RetinAI and Fundación Ver Salud, LuxIA® runs as an independent, AI-based device within the CE-marked RetinAI Discovery® platform.

‍

‍